MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our…

Continue Reading

MondayJul 25, 2022 11:52 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the phase 2 study, an independent data monitoring committee agreed it is safe to allow the enrollment of adolescent patients, defined as persons aged twelve to seventeen with EB. “We are pleased that the initial safety data from InMed’s phase 2 EB clinical trial has allowed…

Continue Reading

MondayJul 25, 2022 11:22 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Launches Revamped ‘Song of the Summer’ Contest

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its “Song of the Summer” contest and artist promotion. According to the update, the submission process opened to artists last week as the company received an immediate positive response with entries pouring in. The contest registration will remain open until July 31, 2022, and fan voting will begin in August 2022 to determine each of the five winners per genre. “This contest has been a highly sought after and anticipated promotion since it began with the former Artist Republik management team,” said Friendable CEO Robert A. Rositano Jr. “Now…

Continue Reading

MondayJul 25, 2022 11:15 am

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis  Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage…

Continue Reading

MondayJul 25, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Realize ESG Strategies Through Comprehensive Energy Analysis and Environmentally Friendly Upgrades to Facilities

Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas impact CIPI’s Correlate, Inc. and Loyal Enterprises LLC (dba Solar Site Design) subsidiaries provide related help on acquisitions and project development, as well as resource financing  A recent report by consulting firm McKinsey & Company forecasts growing adoption of renewable energy solutions by the public,…

Continue Reading

MondayJul 25, 2022 9:45 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Charges Ahead as Clean Tech Company on the Right Track to Providing Optimal Inverter Technology

Hillcrest announces AGM results; all seven members of Board of Directors are re-elected while new board chair David Farrell is appointed Company exits fossil-fuel business and completes transition to clean tech market where it continues to develop inverter technology empowering next generation of more efficient and powerful electric vehicles Hillcrest reaches key milestone as it completes proof of concept testing of its inverter technology, with the commercial prototype soon to be available in Q4 2022 Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a Canadian cleantech company developing technologies for innovative electrical solutions such as powertrains and grid-connected renewable…

Continue Reading

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine months The pivotal study was designed with four primary objectives Cybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://ibn.fm/2Ab0T). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004.  “With the closing of this transaction…

Continue Reading

FridayJul 22, 2022 2:13 pm

QualityStocksNewsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients,” a recent article reads. “CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. … CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters…

Continue Reading

FridayJul 22, 2022 1:50 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology

Silo Pharma (OTCQB: SILO) earlier this year extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and blood vessels). “Silo’s partnership with UMB focuses on peptides used for investigating and treating the arthritogenic process or joint disease. Current treatment for arthritis has side effects that include nausea, vomiting, diarrhea, tinnitus, hair loss, seizures, fever, congestion, unusual lumps or masses, and more. OTC arthritis therapeutics, such as common NSAIDs, can produce stomach ulcers, dizziness and indigestion and can have…

Continue Reading

FridayJul 22, 2022 1:35 pm

QualityStocksNewsBreaks – Why GeoSolar Technologies Inc. Is ‘One to Watch’

GeoSolar Technologies (“GST”) is a Colorado-based climate technology company and creator of the Smart Green Home(R) system for newly built and existing residences and commercial buildings. With soaring and unstable energy/fuel costs highlighting the importance of rethinking the traditional approach, GST is focused on revolutionizing the heating, cooling and powering of homes with 100% natural energy resources. “In a GST home, the sun’s energy is captured on the roof to generate all the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered